Drug-eluting stents for ST-segment elevation myocardial infarction: extending the biodegradable versus durable polymer debate. - Suppr | 超能文献

Drug-eluting stents for ST-segment elevation myocardial infarction: extending the biodegradable versus durable polymer debate.

作者信息

Buiten Rosaly A, Ploumen Eline H

机构信息

Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Enschede 7512 KZ, Netherlands.

Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Enschede 7512 KZ, Netherlands.

出版信息

Lancet. 2023 Nov 25;402(10416):1942-1943. doi: 10.1016/S0140-6736(23)02297-3. Epub 2023 Oct 25.

DOI:10.1016/S0140-6736(23)02297-3

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Drug-eluting stents for ST-segment elevation myocardial infarction: extending the biodegradable versus durable polymer debate.

Lancet. 2023 Nov 25;402(10416):1942-1943. doi: 10.1016/S0140-6736(23)02297-3. Epub 2023 Oct 25.

2

Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial.超薄支架可生物降解聚合物西罗莫司洗脱支架与耐用聚合物依维莫司洗脱支架经皮冠状动脉血运重建（BIOSCIENCE）：一项随机、单盲、非劣效性试验。

Lancet. 2014 Dec 13;384(9960):2111-22. doi: 10.1016/S0140-6736(14)61038-2. Epub 2014 Sep 1.

3

Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial.生物可降解聚合物西罗莫司洗脱支架与耐久性聚合物依维莫司洗脱支架在 ST 段抬高型心肌梗死患者中的比较（BIOSTEMI）：一项单盲、前瞻性、随机优效性试验。

Lancet. 2019 Oct 5;394(10205):1243-1253. doi: 10.1016/S0140-6736(19)31877-X. Epub 2019 Sep 2.

4

Long-term outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in ST-segment elevation myocardial infarction: 5-year follow-up of the BIOSTEMI randomised superiority trial.生物可降解聚合物西罗莫司洗脱支架与持久性聚合物依维莫司洗脱支架治疗 ST 段抬高型心肌梗死的长期疗效：BIOSTEMI 随机优势试验 5 年随访结果。

Lancet. 2023 Nov 25;402(10416):1979-1990. doi: 10.1016/S0140-6736(23)02197-9. Epub 2023 Oct 25.

5

Biodegradable-Polymer Biolimus-Eluting Stents versus Durable-Polymer Everolimus-Eluting Stents at One-Year Follow-Up: A Registry-Based Cohort Study.一年随访期内生物可降解聚合物生物雷帕霉素洗脱支架与耐用聚合物依维莫司洗脱支架的比较：一项基于注册登记的队列研究。

Tex Heart Inst J. 2016 Apr 1;43(2):126-30. doi: 10.14503/THIJ-14-4997. eCollection 2016 Apr.

6

Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.与含有不可降解聚合物的西罗莫司洗脱支架相比，含可生物降解聚合物的比伐卢定洗脱支架在冠状动脉疾病患者中具有更好的安全性和降低支架血栓形成的风险：LEADERS（雷帕霉素从不可降解到可降解涂层支架洗脱）随机、非劣效性试验的最终 5 年报告。

JACC Cardiovasc Interv. 2013 Aug;6(8):777-89. doi: 10.1016/j.jcin.2013.04.011.

7

Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable-Polymer Everolimus-Eluting Stent for Percutaneous Coronary Revascularization: 2-Year Results of the BIOSCIENCE Trial.用于经皮冠状动脉血运重建的超薄支柱可生物降解聚合物西罗莫司洗脱支架与耐用聚合物依维莫司洗脱支架对比：BIOSCIENCE试验的2年结果

J Am Heart Assoc. 2016 Mar 15;5(3):e003255. doi: 10.1161/JAHA.116.003255.

8

Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial.超薄支架、可生物降解聚合物、西罗莫司洗脱支架与薄支架、耐用聚合物、依维莫司洗脱支架经皮冠状动脉血运重建：BIOSCIENCE 随机试验 5 年结果。

Lancet. 2018 Sep 1;392(10149):737-746. doi: 10.1016/S0140-6736(18)31715-X. Epub 2018 Aug 28.

9

Biodegradable-Polymer Sirolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in Patients With Acute ST-Segment Elevation Myocardial Infarction: Insights From the 2-Year Follow-Up of the BIOSCIENCE Trial.

JACC Cardiovasc Interv. 2016 May 9;9(9):981-3. doi: 10.1016/j.jcin.2016.02.044.

10

Biodegradable Polymer Biolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With Coronary Artery Disease: Final 5-Year Report From the COMPARE II Trial (Abluminal Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent).生物可降解聚合物比伐卢定洗脱支架与耐久性聚合物依维莫司洗脱支架治疗冠状动脉疾病患者的比较：来自 COMPARE II 试验的最终 5 年报告（管腔生物可降解聚合物比伐卢定洗脱支架与耐久性聚合物依维莫司洗脱支架）。

JACC Cardiovasc Interv. 2017 Jun 26;10(12):1215-1221. doi: 10.1016/j.jcin.2017.02.029. Epub 2017 May 31.

引用本文的文献

1

The optimal timing for intervention in patients with ST-segment elevation myocardial infarction and multivessel disease: a systematic review and meta-analysis.ST段抬高型心肌梗死合并多支血管病变患者的最佳干预时机：一项系统评价和荟萃分析。

Front Cardiovasc Med. 2024 Aug 9;11:1389017. doi: 10.3389/fcvm.2024.1389017. eCollection 2024.

2

Risk factors for ventricular arrhythmias after emergency percutaneous coronary intervention in elderly patients with acute myocardial infarction.老年急性心肌梗死患者急诊经皮冠状动脉介入治疗后室性心律失常的危险因素

Am J Transl Res. 2024 May 15;16(5):1678-1689. doi: 10.62347/WZNF8280. eCollection 2024.